Bloomage BioTechnology Corporation Limited (SHA:688363)
China flag China · Delayed Price · Currency is CNY
47.18
+2.35 (5.24%)
At close: Feb 2, 2026

SHA:688363 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
4,6505,3616,0756,3594,9472,632
Other Revenue
9.499.490.60.410.551.05
4,6595,3716,0766,3594,9482,633
Revenue Growth (YoY)
-18.67%-11.61%-4.45%28.53%87.93%39.63%
Cost of Revenue
1,3991,4821,6591,4821,118510.98
Gross Profit
3,2603,8894,4174,8773,8292,122
Selling, General & Admin
2,6003,1183,3313,4392,7361,256
Research & Development
514.36466.25446.35388.19284.34141.16
Other Operating Expenses
0.9346.4862.0173.2556.9530.45
Operating Expenses
3,1473,6563,8473,9153,0831,452
Operating Income
113.6232.36570.18961.48746.46670.05
Interest Expense
-11.02-9.17-10.74-14.52-11.08-
Interest & Investment Income
7.4414.1139.7850.4445.0752.19
Currency Exchange Gain (Loss)
2.972.973.925.19-12.05-16.99
Other Non Operating Income (Expenses)
8.69-4.761.71-3.88-2.62-0.77
EBT Excluding Unusual Items
121.68235.51604.841,019765.77704.49
Impairment of Goodwill
-74.09-74.09----
Gain (Loss) on Sale of Investments
-14.67-11.48-18.74-0.147.393.34
Gain (Loss) on Sale of Assets
0.82-0.11-3.42-0.240.040.05
Asset Writedown
-29.81-0.86-1.87-0.53-3.91-0.34
Other Unusual Items
64.4364.43120.91118.32120.951.36
Pretax Income
68.36213.39701.721,136890.2758.9
Income Tax Expense
6.6844.99118.98174.73114.64113.89
Earnings From Continuing Operations
61.68168.41582.74961.38775.56645.01
Minority Interest in Earnings
2.945.869.819.546.780.83
Net Income
64.62174.27592.56970.92782.33645.84
Net Income to Common
64.62174.27592.56970.92782.33645.84
Net Income Growth
-85.32%-70.59%-38.97%24.10%21.14%10.29%
Shares Outstanding (Basic)
486484482481480478
Shares Outstanding (Diluted)
486484482483483478
Shares Change (YoY)
0.59%0.48%-0.27%0.03%0.95%9.47%
EPS (Basic)
0.130.361.232.021.631.35
EPS (Diluted)
0.130.361.232.011.621.35
EPS Growth
-85.41%-70.73%-38.81%24.07%20.00%0.75%
Free Cash Flow
236.62-156.88-330.68-61.22491.85-57.65
Free Cash Flow Per Share
0.49-0.32-0.69-0.131.02-0.12
Dividend Per Share
0.1100.1100.3800.6100.4900.410
Dividend Growth
-71.05%-71.05%-37.70%24.49%19.51%10.81%
Gross Margin
69.97%72.41%72.69%76.69%77.40%80.59%
Operating Margin
2.44%4.33%9.38%15.12%15.09%25.45%
Profit Margin
1.39%3.25%9.75%15.27%15.81%24.53%
Free Cash Flow Margin
5.08%-2.92%-5.44%-0.96%9.94%-2.19%
EBITDA
367.53465.45775.491,124866.92740.23
EBITDA Margin
7.89%8.67%12.76%17.68%17.52%28.12%
D&A For EBITDA
253.94233.1205.31162.69120.4670.19
EBIT
113.6232.36570.18961.48746.46670.05
EBIT Margin
2.44%4.33%9.38%15.12%15.09%25.45%
Effective Tax Rate
9.77%21.08%16.96%15.38%12.88%15.01%
Revenue as Reported
4,6595,3716,0766,3594,9482,633
Advertising Expenses
-1,3771,7902,0511,583618.8
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.